Navigation Links
Genomma Lab, New Participant in Market-Maker Program
Date:1/12/2009

MEXICO CITY, Jan. 12 /PRNewswire-FirstCall/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB) ("Genomma Lab" or "the Company") announced that on January 9, 2009, the Company signed an agreement with IXE Casa de Bolsa, S.A. de C.V. to act as the market maker for the Company's outstanding shares, thus becoming another company to participate in the market maker program. The contract will become valid upon approval of the Mexican Stock Exchange (Bolsa Mexicana de Valores) and will be in effect for a minimum period of 12 months from the date of the agreement.

Less than 6 months since becoming a public company, Genomma Lab seeks to leverage the benefits of the modernizing Mexican markets via the market-maker program. The Company expects that its incorporation into this program will allow for increased share liquidity.

With its incorporation into the market-maker program and together with the Share Repurchase program approved by the Board of Directors, Genomma Lab reaffirms its commitment to provide higher liquidity for its shares.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico with international presence. Genomma develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share.

Genomma Lab performed its Initial Public Offering in June 2008, through a combined offering (mainly primary) and is listed on the Mexican Stock Exchange under the ticker symbol "LAB.B" (Bloomberg: labb.mx).

    Web Site: www.genommalab.com

    Investor Relations Contact:
    Tel: +52 (55) 5081 0000 Ext. 4250
    E-mail: inversion@genommalab.com

    In New York: i-advize Corporate Communications, Inc.
    Tel: (212) 406-3691/95
    E-mail: genomma@i-advize.com

'/>"/>
SOURCE Genomma Lab Internacional, S.A.B. de C.V.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Genomma Lab Announces Initiation of Stock Repurchase Fund
2. Genomma Lab Announces the Successful Launch of the Ma Evans Brand
3. Genomma Lab Announces 2009 Earnings Guidance
4. Genomma Lab Internacional Acquires UNIGASTROZOL
5. Webcast Alert: Genomma Lab Internacional, S.A.B. de C.V. announces Second Quarter 2008 Results Conference Call
6. Genomma Lab Prices Initial Public Offering and Begins Trading on Mexican Stock Exchange
7. Exercising Power to Lead Healthier Lives - 740,000 Participants Cast Votes for Challenger of Year
8. Newport Introduces More Resources for Spanish Speaking Plan Participants
9. Retired Heart Surgeon Dr. Dwight Lundell Celebrates 65th Birthday as an Ironman Participant
10. 25,000 AIDS Walk San Francisco Participants; 25,000 Reasons Why
11. Fight Against Breast Cancer Receives Big Boost During Susan G. Komen Detroit Race for the Cure(R) With 344 Participants From Binsons, Northwood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
(Date:6/24/2016)... Frederick, Maryland (PRWEB) , ... June 24, 2016 ... ... Mid-Atlantic Angels is actively feeding the Frederick area economy by obtaining investment capital ... support over the past 2½ years that have already resulted in more than ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
Breaking Medicine Technology: